Cote d'Ivoire vs Dominican Republic: Access to anti-retroviral drugs, male
Cote d'Ivoire
69.0%
in 2024
Dominican Republic
68.0%
in 2024
Cote d'Ivoire rank
72nd
Dominican Republic rank
73rd
Access to anti-retroviral drugs, male over time
- Cote d'Ivoire
- Dominican Republic
How they compare
Cote d'Ivoire currently reports 69.0% against 68.0% in Dominican Republic, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Dominican Republic ahead.
Cote d'Ivoire ranks 72nd and Dominican Republic ranks 73rd of 141 countries.
Across the 3 decades both report, Cote d'Ivoire averaged higher in 1 and Dominican Republic in 2.
Head to head by decade
| Decade | Cote d'Ivoire | Dominican Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.4% | 4.5% | 1.1% | Dominican Republic |
| 2010s | 28.6% | 30.8% | 2.2% | Dominican Republic |
| 2020s | 61.2% | 59.2% | 2.0% | Cote d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Cote d'Ivoire or Dominican Republic?
- Cote d'Ivoire, at 69.0% against 68.0% in Dominican Republic as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Cote d'Ivoire and Dominican Republic?
- 1.0%, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Cote d'Ivoire and Dominican Republic?
- 25 years are reported by both, from 2000 to 2024.
- How do Cote d'Ivoire and Dominican Republic rank globally for access to anti-retroviral drugs, male?
- Cote d'Ivoire ranks 72nd and Dominican Republic ranks 73rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.